- Home
- COEP vs ASPS Comparison
COEP vs ASPS Comparison
Compare COEP & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | ASPS |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | Luxembourg |
| Employees | 7 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 64.0M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | COEP | ASPS |
|---|---|---|
| Price | $11.72 | $6.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.8K | ★ 42.3K |
| Earning Date | 01-01-0001 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 112.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $942,213,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $42.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.32 | $0.65 |
| 52 Week High | $21.41 | $15.96 |
Technical Indicators
Market Signals| Indicator | COEP | ASPS |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 50.45 |
| Support Level | $10.98 | $6.07 |
| Resistance Level | $13.23 | $6.47 |
| Average True Range (ATR) | 0.94 | 1.00 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 41.06 | 16.40 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.